Additionally, Moody’s affirmed the “A3” rating on Parkview Medical Center’s outstanding bonds, affecting $169 million of rated parity debt.
The affirmation and assignment are based on several factors, including PMC’s solid market position, conservative asset liability policies and healthy balance sheet metrics. Moody’s also acknowledged the medical center’s highly competitive market, variable operating performance, high debt load and unfavorable payer mix.
The outlook is stable, reflecting Moody’s expectation that the medical center will maintain its market position and balance sheet metrics to gradually lower its debt burden.
More articles on healthcare finance:
Ascension’s net income more than triples to $1.8B
Sen. Grassley: Tax-exempt hospitals shouldn’t need ‘herculean oversight’ to meet charitable obligations
California hospital’s reporting errors cause Medicare to overpay 173 other facilities
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
